Generic Name ABACAVIR/DOLUTEGRAVIR/LAMIVUDI Review Date Began Mon, 04/11/2022 - 12:00 Review Date Completed Mon, 06/06/2022 - 12:00 Conclusion PDL Edit Committee Month Thu, 09/01/2022 - 12:00 Sat, 10/01/2022 - 12:00